Zynex Welcomes Bret Wise as New Audit Committee Chair

Zynex Welcomes a New Leader to its Board

Zynex, Inc. (NASDAQ: ZYXI), a pioneer in innovative medical technology, specializes in the manufacture and sale of non-invasive devices aimed at pain management and rehabilitation. The company has recently appointed Bret Wise to its Board of Directors. Alongside his board role, Wise will also chair the company's Audit Committee.

Dynamic Leadership for Financial Oversight

Steven Dyson, the CEO of Zynex, expressed enthusiasm over Wise’s appointment, stating that he is a great addition to the board. Dyson emphasized the company’s renewed focus on patient and customer success, complemented by a commitment to integrity and compliance. With Mr. Wise’s extensive experience, the company aims to enhance its operational and financial management.

Bret Wise’s Extensive Experience in Medical Devices

Bret Wise brings an impressive background to Zynex, with significant operational and financial management experience in the medical device sector. From 2007 to 2016, he served as Chair and CEO of Dentsply International, followed by a tenure as Executive Chair of Dentsply Sirona until 2017. His career has seen him in various distinguished roles, including President, COO, and CFO within the same organization.

Strategic Contributions to the Medical Device Landscape

Prior to joining Dentsply, Mr. Wise was also CFO for two publicly traded companies and an audit partner with KPMG. His diverse experiences extend to two other public boards, IMS Health Inc. and Pall Corporation. Additionally, he currently contributes to Zest Dental Solutions and the Clinical Advisory Board of the Kansas City University College of Dental Medicine.

A Pivotal Role at Zynex

In his new role, Wise stated, "I am honored to take on this role as Chair of the Audit Committee at such a pivotal time for Zynex." He looks forward to collaborating with fellow board members and the management team to pave the way forward for the company.

Commitment to Financial Integrity

Thomas Sandgaard, the founder and Chair of the Board, expressed pride in welcoming Wise. He noted that Bret's financial expertise will be invaluable as the company maintains its commitment to high standards of financial oversight and transparency. This appointment aligns with Zynex's mission to provide exceptional medical technologies while ensuring responsible financial practices.

Future Prospects

In the context of ongoing challenges in the medical device field, Zynex aims to leverage Wise's expertise to navigate market uncertainties and regulatory requirements effectively. Armed with smart strategies and innovative approaches, the company is ready to embrace future opportunities.

About Zynex, Inc.

Founded in 1996, Zynex develops, manufactures, markets, and sells medical devices for pain management and rehabilitation. Their innovative offerings also include non-invasive monitoring systems for fluid management, sepsis, and laser-based pulse oximetry used in clinical settings.

Investor Relations Contact

Vikram Bajaj, CFO

Frequently Asked Questions

What is Zynex's primary focus as a company?

Zynex focuses on manufacturing non-invasive medical devices for pain management and rehabilitation.

Who is Bret Wise?

Bret Wise is the newly appointed Chair of the Audit Committee at Zynex and has extensive experience in the medical device industry.

What roles did Bret Wise have before joining Zynex?

Prior to his role at Zynex, Wise held significant leadership positions at Dentsply International and KPMG.

Why is Wise's appointment important for Zynex?

His financial expertise is expected to enhance Zynex's commitment to financial oversight and transparency.

When was Zynex founded?

Zynex was founded in 1996 and has grown to be a leader in medical device innovation.

About The Author

Hi there I'm 38-year-old author and financial consultant Owen Jenkins. Having worked in the financial sector for more than ten years, I am well-versed in the subtleties and complexity that mold our financial environment. Following a degree in finance, I worked in a number of financial institutions honing my abilities in market analysis, financial planning, and investment strategies.

My love is teaching others about investing and personal finance. My goal in writing many books and articles has been to demystify financial ideas and give readers the information they need to make wise financial decisions. I write with a direct, useful style that emphasizes doable suggestions for daily living.

Along with writing, I lead webinars and seminars where I impart knowledge on how to successfully negotiate the financial world. I also write for financial journals and show up as a guest expert on financial news programs a lot. Whether they are new to investing or want to improve their approach, my mission is to enable people to take charge of their financial futures.

Beyond work, I like to hike, play the guitar, and spend time with my family. I think that balance is crucial and want to encourage people to strike a balance between their financial aspirations and their hobbies. I want to help people succeed and achieve financial security through my work, so having a good influence.

Contact Owen Jenkins privately here. Or send an email with ATTN: Owen Jenkins as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.